Jacqueline A James Selected Research

Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)

2/2021

Identifying mismatch repair-deficient colon cancer: near-perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population-based series.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jacqueline A James Research Topics

Disease

16	Neoplasms (Cancer) 11/2023 - 03/2012
10	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 04/2017
6	Colonic Neoplasms (Colon Cancer) 08/2022 - 04/2017
3	Adenocarcinoma 01/2020 - 09/2018
2	Disease Progression 01/2023 - 10/2020
2	Microsatellite Instability 01/2022 - 02/2021
2	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2020 - 03/2012
2	Breast Neoplasms (Breast Cancer) 01/2018 - 12/2015
1	Polyps 03/2023
1	Adenomatous Polyps 03/2023
1	COVID-19 07/2021
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 02/2021
1	Bites and Stings (Sting) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Hypoxia (Hypoxemia) 10/2020
1	Atrial Fibrillation 08/2020
1	Spontaneous Remission 08/2020
1	Stroke (Strokes) 08/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Carcinoma (Carcinomatosis) 03/2016
1	Otodental Dysplasia 12/2015
1	Pharyngeal Neoplasms 07/2013
1	Adenocarcinoma of Lung 08/2011
1	Lung Neoplasms (Lung Cancer) 08/2011
1	Periodontitis 02/2007
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2003
1	Leukemia 01/2003

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 11/2023 - 03/2012
6	Proteins (Proteins, Gene)FDA Link 08/2022 - 08/2011
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 09/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2015
2	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2020
2	Immune Checkpoint InhibitorsIBA 01/2021 - 07/2017
2	Messenger RNA (mRNA)IBA 10/2020 - 08/2011
1	HMGB1 Protein (HMG1)IBA 03/2023
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	SuspensionsIBA 07/2021
1	VaccinesIBA 07/2021
1	CathelicidinsIBA 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	ParaffinIBA 10/2020
1	Calcibiotic Root Canal SealerIBA 10/2020
1	Formaldehyde (Formol)FDA Link 10/2020
1	Tyrosine Kinase InhibitorsIBA 08/2020
1	PlatinumIBA 11/2019
1	Calcitriol Receptors (Calcitriol Receptor)IBA 09/2018
1	bcl-X ProteinIBA 01/2018
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2018
1	Keratins (Keratin)IBA 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2017
1	Coenzyme A (CoA)IBA 06/2017
1	Oxidoreductases (Dehydrogenase)IBA 06/2017
1	Mevalonic Acid (Mevalonate)IBA 06/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2017
1	Indicators and Reagents (Reagents)IBA 03/2016
1	Nucleic AcidsIBA 09/2015
1	Protein Isoforms (Isoforms)IBA 07/2013
1	Toll-Like Receptor 4IBA 02/2007
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2003
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2003
1	U 0126 (UO 126)IBA 01/2003

Therapy/Procedure

4	Therapeutics 06/2021 - 02/2017
2	Drug Therapy (Chemotherapy) 11/2019 - 01/2003
2	Adjuvant Chemotherapy 09/2018 - 01/2018
1	Immunotherapy 01/2021
1	Electric Countershock (Cardioversion) 08/2020
1	Radiotherapy 08/2020
1	Neoadjuvant Therapy 11/2019
1	Oral Pathology 12/2015